This content is machine translated Ozanimod for relapsing-remitting multiple sclerosis Signs of improved tolerability with prolonged treatment Ozanimod, a selective modulator of sphingosine-1-phosphate (S1P) receptors 1 and 5, has demonstrated efficacy in relapsing-remitting multiple sclerosis (RMS) in Phase 2 and 3 studies. At a dose of 0.92...…
